| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Analysis of Clinicopathologic Prognostic Factors in 9 Patients With Epithelioid Trophoblastic Tumor
|
Shen, Xiaoyan
|
|
|
21 |
6 |
p. 1124-1130
|
artikel
|
| 2 |
CHFR Suppression by Hypermethylation Sensitizes Endometrial Cancer Cells to Paclitaxel
|
Wang, Xiaoyun
|
|
|
21 |
6 |
p. 996-1003
|
artikel
|
| 3 |
Clinical Study on the Efficacy of Fluvoxamine for Psychological Distress in Gynecologic Cancer Patients
|
Suzuki, Nao
|
|
|
21 |
6 |
p. 1143-1149
|
artikel
|
| 4 |
Comparison of the Efficacy and Toxicity Between Radiotherapy and Chemotherapy in Nodal and Isolated Nonnodal Recurrence of Ovarian Cancer
|
Lee, Maria
|
|
|
21 |
6 |
p. 1032-1039
|
artikel
|
| 5 |
Defining Prognostic Variables in Recurrent Endometrioid Endometrial Cancer
|
Esselen, Katharine M.
|
|
|
21 |
6 |
p. 1078-1083
|
artikel
|
| 6 |
Double Prophylaxis for Deep Venous Thrombosis in Patients With Gynecologic Oncology Who Are Undergoing Laparotomy
|
Whitworth, Jenny M.
|
|
|
21 |
6 |
p. 1131-1134
|
artikel
|
| 7 |
Editorial
|
Beller, Uziel
|
|
|
21 |
6 |
p. 965
|
artikel
|
| 8 |
Effects of Bufalin on the Proliferation of Human Choriocarcinoma Cells
|
Takai, Noriyuki
|
|
|
21 |
6 |
p. 1105-1109
|
artikel
|
| 9 |
Expression of ERCC1, p53, and Class III A-Tubulin Do Not Reveal Chemoresistance in Endometrial Cancer
|
Vandenput, Ingrid
|
|
|
21 |
6 |
p. 1071-1077
|
artikel
|
| 10 |
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma
|
Cheng, Rong-jie
|
|
|
21 |
6 |
p. 1004-1012
|
artikel
|
| 11 |
Expression of αV-Integrins in Uterine Serous Papillary Carcinomas; Implications for Targeted Therapy With Intetumumab (CNTO 95), a Fully Human Antagonist Anti – αV-Integrin Antibody
|
Bellone, Marta
|
|
|
21 |
6 |
p. 1084-1090
|
artikel
|
| 12 |
Feasibility of a Modified Outpatient Regimen of Intravenous/Intraperitoneal Chemotherapy in Optimally Debulked Stage III Ovarian Cancer Patients
|
Oaknin, Ana
|
|
|
21 |
6 |
p. 1048-1055
|
artikel
|
| 13 |
18F-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Standard Uptake Value Ratio as an Indicator of Cervical Cancer Chemoradiation Therapeutic Response
|
Kunos, Charles
|
|
|
21 |
6 |
p. 1117-1123
|
artikel
|
| 14 |
Hydronephrosis as a Prognostic Indicator of Survival in Advanced Cervix Cancer
|
Pradhan, Tana S.
|
|
|
21 |
6 |
p. 1091-1096
|
artikel
|
| 15 |
Management of Cancer During Pregnancy Obstetric and Neonatal Outcomes
|
Lataifeh, Isam M.
|
|
|
21 |
6 |
p. 1159-1164
|
artikel
|
| 16 |
Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer
|
du Bois, Andreas
|
|
|
21 |
6 |
p. 1165-1168
|
artikel
|
| 17 |
Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer
|
Skaznik-Wikiel, Malgorzata E.
|
|
|
21 |
6 |
p. 1013-1017
|
artikel
|
| 18 |
Preoperative Bowel Preparation in Gynecologic Oncology
|
Wells, Tiffany
|
|
|
21 |
6 |
p. 1135-1142
|
artikel
|
| 19 |
Preoperative Multimodal Strategies for Risk Assessment of Adnexal Masses
|
Radosa, Marc Philipp
|
|
|
21 |
6 |
p. 1056-1062
|
artikel
|
| 20 |
Prevalence of Human Papillomavirus Infection in Women in Portugal The CLEOPATRE Portugal Study
|
Pista, Angela
|
|
|
21 |
6 |
p. 1150-1158
|
artikel
|
| 21 |
Prognostic Impact of Concomitant p53 and PTEN on Outcome in Early Stage (FIGO I-II) Epithelial Ovarian Cancer
|
Skrnisdttir, Ingiridur
|
|
|
21 |
6 |
p. 1024-1031
|
artikel
|
| 22 |
Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
|
Steffensen, Karina Dahl
|
|
|
21 |
6 |
p. 1040-1047
|
artikel
|
| 23 |
Reasons for Diagnostic Delay in Gynecological Malignancies
|
Vandborg, Mai Partridge
|
|
|
21 |
6 |
p. 967-974
|
artikel
|
| 24 |
Re: “Parametrial Involvement in FIGO Stage IB1 Cervical Carcinoma”
|
Thomas, Gillian M.
|
|
|
21 |
6 |
p. 966
|
artikel
|
| 25 |
Reporting and Validation of Gynaecological Groupe Euopeen de Curietherapie European Society for Therapeutic Radiology and Oncology (ESTRO) Brachytherapy Recommendations for mR Image-Based Dose Volume Parameters and Clinical Outcome With High Dose-Rate Brachytherapy in Cervical Cancers A Single-Institution Initial Experience
|
Mahantshetty, Umesh
|
|
|
21 |
6 |
p. 1110-1116
|
artikel
|
| 26 |
Silencing of CXCR4 Blocks Progression of Ovarian Cancer and Depresses Canonical Wnt Signaling Pathway
|
Wang, Jia
|
|
|
21 |
6 |
p. 981-987
|
artikel
|
| 27 |
Surgical and Medical Treatment of Clear Cell Ovarian Cancer
|
Magazzino, Francescapaola
|
|
|
21 |
6 |
p. 1063-1070
|
artikel
|
| 28 |
The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro
|
Deng, Dongrui
|
|
|
21 |
6 |
p. 988-995
|
artikel
|
| 29 |
Trends and Patterns of Ovarian Cancer Mortality in Belgrade, Serbia
|
Tepavcevic, Darija Kisic
|
|
|
21 |
6 |
p. 1018-1023
|
artikel
|
| 30 |
Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer
|
Schmid, Seraina
|
|
|
21 |
6 |
p. 975-980
|
artikel
|
| 31 |
YY1 Is a Novel Potential Therapeutic Target for the Treatment of HPV Infection-Induced Cervical Cancer by Arsenic Trioxide
|
He, Guifen
|
|
|
21 |
6 |
p. 1097-1104
|
artikel
|
Tijdschrift beschrijving